Put th1902 on the burnerI mean this is not Pfizer doing clinical trials... they missed the financing window and now like for Nash their Cancer trial can't go anywhere considering their cash balance. Maybe they can keep it alive by not killing it but try to get a pharma onboard for the platform. Otherwise they have no money for this. Cut your R&D staff and cut the fat in that crazy 165 employe number... nuts...